中国临床新医学
中國臨床新醫學
중국림상신의학
Chinese Journal of New Clinical Medicine
2015年
10期
958-961
,共4页
吴升祥%张国龙%张磊%张振洲%赵贤军
吳升祥%張國龍%張磊%張振洲%趙賢軍
오승상%장국룡%장뢰%장진주%조현군
鼻蝶入路%垂体瘤%复发%二次手术
鼻蝶入路%垂體瘤%複髮%二次手術
비접입로%수체류%복발%이차수술
Transsphenoidal%Pituitary tumor%Recurrence%Reoperation
目的:探讨内镜下经鼻蝶入路二次手术治疗复发垂体瘤患者的临床有效性及安全性,并总结手术操作技巧。方法选取2008-03~2014-02在兰州市第一人民医院脑外科住院的垂体瘤复发患者245例,患者初次垂体瘤手术方式为经蝶入路或开颅手术,后给予其二次内镜下经鼻蝶手术治疗,观察患者瘤体切除程度、术后视力及内分泌变化及并发症的发生情况,分析二次经蝶入路手术治疗垂体瘤的有效性及安全性。结果内镜下经鼻蝶入路二次手术治疗垂体瘤全切加次全切除率达80.38%,无严重并发症发生,无死亡病例。结论内镜下经鼻蝶入路二次手术治疗复发垂体瘤安全有效,值得临床推广应用。
目的:探討內鏡下經鼻蝶入路二次手術治療複髮垂體瘤患者的臨床有效性及安全性,併總結手術操作技巧。方法選取2008-03~2014-02在蘭州市第一人民醫院腦外科住院的垂體瘤複髮患者245例,患者初次垂體瘤手術方式為經蝶入路或開顱手術,後給予其二次內鏡下經鼻蝶手術治療,觀察患者瘤體切除程度、術後視力及內分泌變化及併髮癥的髮生情況,分析二次經蝶入路手術治療垂體瘤的有效性及安全性。結果內鏡下經鼻蝶入路二次手術治療垂體瘤全切加次全切除率達80.38%,無嚴重併髮癥髮生,無死亡病例。結論內鏡下經鼻蝶入路二次手術治療複髮垂體瘤安全有效,值得臨床推廣應用。
목적:탐토내경하경비접입로이차수술치료복발수체류환자적림상유효성급안전성,병총결수술조작기교。방법선취2008-03~2014-02재란주시제일인민의원뇌외과주원적수체류복발환자245례,환자초차수체류수술방식위경접입로혹개로수술,후급여기이차내경하경비접수술치료,관찰환자류체절제정도、술후시력급내분비변화급병발증적발생정황,분석이차경접입로수술치료수체류적유효성급안전성。결과내경하경비접입로이차수술치료수체류전절가차전절제솔체80.38%,무엄중병발증발생,무사망병례。결론내경하경비접입로이차수술치료복발수체류안전유효,치득림상추엄응용。
Objective To investigate the effectiveness and safety of the endoscopic transnasal transsphenoi-dal method and endoscopic transsphenoidal surgery for the treatment of craniotomy or microscopic tumor with relapsed after resection of pituitary.Methods Two hundred and forty-five patients with pituitary tumor recurrence were col-lected from March 2008 to February 2014,who were performed by transsphenoidal or craniotomy for the first opera-tion.All the patients were included in this study and were given secondary endoscopic transsphenoidal surgery.Tumor resection extent,endocrine changes in visual acuity and complications were analyzed.Results The surgery subtotal resection rate was 80.38%,without dead cases and serious complications.Conclusion Endoscopic transsphenoidal resection of pituitary tumors is safe and effective.